{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:19:49Z","timestamp":1789975189768,"version":"4.0.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jpba.2015.06.012","type":"journal-article","created":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T17:03:25Z","timestamp":1434387805000},"page":"341-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Development of a sensitive and rapid method for rifampicin impurity analysis using supercritical fluid chromatography"],"prefix":"10.1016","volume":"114","author":[{"given":"Wei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Yu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2015.06.012_bib0005","unstructured":"International Conference on Harmonization (ICH) Guideline, Q3A(R2):Impurities in New Drug Substances, http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q3A_R2\/Step4\/Q3A_R2__Guideline.pdf(accessed 20.4.15)."},{"key":"10.1016\/j.jpba.2015.06.012_bib0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.chroma.2005.09.080","article-title":"\u201cOrthogonal\u201d separations for reversed-phase liquid chromatography","volume":"1101","author":"Pellett","year":"2006","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2015.06.012_bib0015","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000386837","article-title":"Chemical and biological properties of rifampicin","volume":"16","author":"Furesz","year":"1970","journal-title":"Antibiot. Chemother."},{"key":"10.1016\/j.jpba.2015.06.012_bib0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jpba.2007.10.025","article-title":"HPLC determination of rifampicin and related compounds in pharmaceuticals using monolithic column","volume":"46","author":"Liu","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.06.012_bib0025","unstructured":"State Pharmacopoeia committee, Pharmacopooeia of the People\u2019s Republic of China, part II, 2010, 358\u2013359."},{"key":"10.1016\/j.jpba.2015.06.012_bib0030","first-page":"19","article-title":"development and validation of liquid chromatographic method for the determination of the related substances of rifampicin","volume":"11","author":"Zhu","year":"2002","journal-title":"J. Chin. Pharm Sci."},{"key":"10.1016\/j.jpba.2015.06.012_bib0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jpba.2014.07.027","article-title":"Ascorbic acid improves stability and pharmacokinetics of rifampicinin the presence of isoniazid","volume":"100","author":"Rajaram","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.06.012_bib0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jpba.2013.02.019","article-title":"Comparison of supercritical fluid chromatography and reverse phase liquid chromatography for the impurity profiling of the antiretroviral drugs lamivudine\/ BMS-986001\/efavirenz in a combination tablet","volume":"78\u201379","author":"Alexander","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.06.012_bib0045","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.chroma.2011.02.027","article-title":"Development of an orthogonal method for mometasone furoate impurity analysis using supercritical fluid chromatography","volume":"1218","author":"Wang","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2015.06.012_bib0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.chroma.2008.01.050","volume":"1185","author":"Brunelli","year":"2008","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2015.06.012_bib0055","doi-asserted-by":"crossref","first-page":"8551","DOI":"10.1016\/j.chroma.2011.09.029","volume":"1218","author":"M. de la Puente","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2015.06.012_bib0060","unstructured":"European Pharmacopoeia 8.0, 3165\u20133166."},{"key":"10.1016\/j.jpba.2015.06.012_bib0065","unstructured":"British Pharmacopoeia 2013, monograph 0052."},{"key":"10.1016\/j.jpba.2015.06.012_bib0070","unstructured":"United States Pharmacopeia, 36th ed. 5041\u20135042."},{"key":"10.1016\/j.jpba.2015.06.012_bib0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.chroma.2008.02.097","article-title":"Spectral correlation of high-performance liquid chromatography-diode array detection data from two independent chromatographic runs: peak tracking in pharmaceutical impurity profiling","volume":"1190","author":"Li","year":"2008","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2015.06.012_bib0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpba.2012.05.025","article-title":"Evaluation of mobile phase gradient supercritical fluid chromatography for impurity profiling of pharmaceutical compounds","volume":"70","author":"Alexander","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.06.012_bib0085","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/jaoac\/94.2.531","article-title":"substitute technology for reference substances in the analysis of impurities in cefonicid for injection with HPLC using a diode array detector","volume":"94","author":"Li","year":"2011","journal-title":"J. AOAC Int."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515300303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515300303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T13:28:23Z","timestamp":1599139703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708515300303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":17,"alternative-id":["S0731708515300303"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2015.06.012","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a sensitive and rapid method for rifampicin impurity analysis using supercritical fluid chromatography","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2015.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}